Polaris Rx Named Exclusive U.S. Distributor for AstraZeneca’s FluMist Home Service
Polaris Rx Selected Again as Exclusive U.S. Distributor for FluMist Home for 2026–2027 Flu Season Polaris Rx, a provider of long-term care, specialty and infusion pharmacy solutions, has been selected…
BioIVT to Showcase New Research at Fall Scientific Events
BioIVT to Showcase Translational Research Strategies for Metabolic Disease, GLP-1 Therapies and Emerging Drug Development Models BioIVT, a global research partner and biospecimen solutions provider supporting drug and diagnostic development,…
Pilatus Biosciences to Present Phase 1 PLT012 Data at ESMO 2026
Pilatus Biosciences to Present Phase 1 PLT012 Clinical Trial at ESMO Congress 2026 Pilatus Biosciences, a biopharmaceutical company focused on developing novel metabolic checkpoint immunotherapies for cancer, announced that its…
Corcept Announces Leadership Transition
Corcept Therapeutics Names Justin Gunn President of Endocrinology Division as Sean Maduck Retires Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on developing and commercializing medicines that modulate…
Cellares and Seoul National University Hospital Launch Gene Therapy Manufacturing Proof-of-Concept
Cellares and Seoul National University Hospital Partner to Automate Manufacturing of Gene-Modified HSPC Therapy for PNH Cellares, an Integrated Development and Manufacturing Organization (IDMO), and Seoul National University Hospital (SNUH),…
Neupath Health to Host Annual Physician Forum on Clinical Education
NeuPath Health to Host 2026 Physician Forum Focused on Advances in Chronic and Musculoskeletal Pain Care NeuPath Health Inc. (TSXV: NPTH), a Canadian healthcare company operating one of the country’s…
Aurion Biotech Completes Enrollment in Phase 3 ASTRA Study of AURN001 for Corneal Edema
Aurion Biotech Completes Enrollment in U.S. Phase 3 ASTRA Study of Regenerative Cell Therapy AURN001 Aurion Biotech, Inc., a commercial-stage regenerative cell therapy company focused on restoring vision, has announced…
ImmunoScape Names Peter Olagunju as CEO
ImmunoScape Appoints Peter Olagunju as CEO to Advance TCR-Based Cancer Immunotherapy Platform Toward the Clinic ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI, has appointed Peter…
StandardX Raises £10M to Advance Rare Isotope Production for Medicine and Fusion
StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed…
Autobahn Reports AMPLIFY-BD Results for Elunetirom in Bipolar Depression
Autobahn Therapeutics Reports Positive Phase 2 AMPLIFY-BD Results for Elunetirom in Bipolar Depression Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people living with neuropsychiatric disorders, announced the…
GreenMan’s InSightVR Study Shows Improved Cataract Patient Understanding and IOL Selection
GreenMan Vision Study Finds Virtual Reality May Improve Cataract IOL Education and Patient Satisfaction GreenMan Vision, Inc. has announced the publication of a peer-reviewed, multi-center study evaluating InSightVR, a patient-specific…
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel Pattern Bioscience, a company developing rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug…